Figure 1.
Study design and metabolomics profiling of COVID-19 sera. Overview of cohort (including 30 healthy control samples, 74 ordinary COVID-19 patients, 33 severe COVID-19 patients, and 62 critical COVID-19 patients), and the study design (including metabolomics LC-MS/MS, database search, clinical data, and analysis).